A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2015
At a glance
- Drugs Peptide T (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 13 Oct 2005 New trial record.